You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MEK1

Showing 476 - 499 of 499
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chromophobe Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma Trial in Boston, Philadelphia,

Completed
Has Results
  • Chromophobe Renal Cell Carcinoma
  • +5 more
  • Bevacizumab
  • +3 more
  • Boston, Massachusetts
  • +4 more
Jan 6, 2015

Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer

Completed
Has Results
  • Adult Primary Hepatocellular Carcinoma
  • +3 more
  • Tampa, Florida
  • +5 more
May 12, 2014

Melanoma, Colonic Tumors, Breast Tumors Trial in United States (PD-0325901)

Terminated
  • Melanoma
  • +2 more
  • Birmingham, Alabama
  • +16 more
Sep 11, 2013

Recurrent Melanoma, Stage IIIA Melanoma, Stage IIIB Melanoma Trial in United States (Akt inhibitor MK2206, selumetinib,

Terminated
Has Results
  • Recurrent Melanoma
  • +4 more
  • Akt inhibitor MK2206
  • +2 more
  • Atlanta, Georgia
  • +3 more
May 16, 2014

Hormone Refractory Prostate Cancer Trial in Tianjin (Docetaxel & Prednisone, DP & Targeted drugs, cisplatin & Etoposide)

Unknown status
  • Hormone Refractory Prostate Cancer
  • Docetaxel & Prednisone
  • +3 more
  • Tianjin, Tianjin, China
    Department of Interventional Oncology, Tianjin Medical Universit
Aug 4, 2014

Advanced Solid Tumours Trial in United Kingdom (WX-554)

Terminated
  • Advanced Solid Tumours
  • Belfast, United Kingdom
  • +4 more
May 15, 2014

Recurrent Melanoma, Stage IIIA Melanoma, Stage IIIB Melanoma Trial in New Haven, Minneapolis (dasatinib)

Completed
Has Results
  • Recurrent Melanoma
  • +4 more
  • New Haven, Connecticut
  • +1 more
Apr 29, 2014

Cancer Trial in Australia, United States (GSK1120212)

Completed
Has Results
  • Cancer
  • Los Angeles, California
  • +9 more
Feb 13, 2014

Healthy Volunteers Pharmacokinetic Study Trial in London (Selumetinib)

Completed
  • Healthy Volunteers Pharmacokinetic Study
  • London, United Kingdom
    Research Site
May 30, 2014

Mucosal Melanoma, Recurrent Melanoma, Stage IV Melanoma Trial in Tampa (temsirolimus, selumetinib, laboratory biomarker

Terminated
Has Results
  • Mucosal Melanoma
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Apr 29, 2014

Cancer Trial in Worldwide (GSK1120212)

Completed
Has Results
  • Cancer
  • Birmingham, Alabama
  • +27 more
Mar 6, 2014

Sarcoma Trial in United States (sorafenib)

Completed
Has Results
  • Sarcoma
  • Tucson, Arizona
  • +183 more
May 5, 2014

Colorectal Cancer Trial in Delft, Den Haag, Leiden (biological, drug, other)

Unknown status
  • Colorectal Cancer
  • panitumumab
  • +2 more
  • Delft, Netherlands
  • +3 more
Sep 16, 2013

Carcinoma, Hepatocellular Trial in Worldwide (BAY86-9766 MEK Inhibitor + Sorafenib)

Completed
  • Carcinoma, Hepatocellular
  • BAY86-9766 MEK Inhibitor + Sorafenib
  • Shatin, New Territories, Hong Kong
  • +14 more
Sep 5, 2013

NSCLC Trial in Guangzhou (sorafenib (Nexavar))

Completed
  • Non-Small Cell Lung Cancer
  • sorafenib (Nexavar)
  • Guangzhou, Guangdong, China
    WuYiLong
Aug 19, 2013

Colorectal Cancer Trial in Breda, Leiden (biological, drug, other)

Unknown status
  • Colorectal Cancer
  • cetuximab
  • +2 more
  • Breda, Netherlands
  • +1 more
Aug 9, 2013

Breast Cancer Trial in United States (MRI/MRS, gadopentetate dimeglumine)

Completed
  • Breast Cancer
  • MRI/MRS
  • gadopentetate dimeglumine
  • Birmingham, Alabama
  • +10 more
Oct 7, 2013

Advanced Non-hematologic Malignancies, Advanced Metastatic Melanoma Trial in Detriot, Buffalo (TAK-733)

Completed
  • Advanced Non-hematologic Malignancies
  • Advanced Metastatic Melanoma
  • Detriot, Michigan
  • +1 more
Jul 1, 2013

Cancer Trial in Korea, Republic of, Taiwan (GSK1120212, Gemcitabine, Placebo)

Completed
Has Results
  • Cancer
  • Seoul, Korea, Republic of
  • +6 more
Jul 25, 2013

Liver Cancer Trial in Chapel Hill, Durham (sorafenib tosylate)

Terminated
  • Liver Cancer
  • sorafenib tosylate
  • Chapel Hill, North Carolina
  • +1 more
May 22, 2012

Non-Small-Cell Lung Carcinoma Trial run by the NCI (BAY 43-9006 (Sorafenib))

Completed
Has Results
  • Non-Small-Cell Lung Carcinoma
  • BAY 43-9006 (Sorafenib)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 3, 2012

Osteoporosis, Osteopenia Trial in Pittsburgh (melatonin, sugar pill)

Completed
Has Results
  • Osteoporosis
  • Osteopenia
  • melatonin
  • sugar pill
  • Pittsburgh, Pennsylvania
    Duquesne University School of Pharmacy Center for Pharmacy Care
Mar 9, 2012

Hepatocellular Carcinoma Trial in Pisa (Infusional 5-Fluorouracil, Sorafenib (Bay 43-9006))

Completed
  • Hepatocellular Carcinoma
  • Infusional 5-Fluorouracil
  • Sorafenib (Bay 43-9006)
  • Pisa, Italy
    Dipartimento di Oncologia, dei Trapianti e delle Nuove Tecnologi
Feb 25, 2009

Prostate Cancer Trial in Pisa (Sorafenib (Nexavar), Docetaxel)

Completed
  • Prostate Cancer
  • Pisa, Italy
    Dipartimento di Oncologia, dei Trapianti e delle Nuove Tecnologi
Feb 25, 2009